Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Actuarial Approach01:20

Actuarial Approach

286
The actuarial approach, a statistical method originally developed for life insurance risk assessment, is widely used to calculate survival rates in clinical and population studies. This method accounts for participants lost to follow-up or those who die from causes unrelated to the study, ensuring a more accurate representation of survival probabilities.
Consider the example of a high-risk surgical procedure with significant early-stage mortality. A two-year clinical study is conducted,...
286
Cancer Survival Analysis01:21

Cancer Survival Analysis

645
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
645
Kaplan-Meier Approach01:24

Kaplan-Meier Approach

574
The Kaplan-Meier estimator is a non-parametric method used to estimate the survival function from time-to-event data. In medical research, it is frequently employed to measure the proportion of patients surviving for a certain period after treatment. This estimator is fundamental in analyzing time-to-event data, making it indispensable in clinical trials, epidemiological studies, and reliability engineering. By estimating survival probabilities, researchers can evaluate treatment effectiveness,...
574

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

A robust cd-based coordination polymer with high sensitivity for fluorescent detection of cefixime in environmental water and milk samples.

Spectrochimica acta. Part A, Molecular and biomolecular spectroscopy·2026
Same author

Reply to: "IFRD1: a promising target in human liver regeneration".

Journal of hepatology·2026
Same author

Clinicopathological characteristics and therapeutic outcomes of Kimura disease: A real-world study.

British journal of haematology·2026
Same author

Development of a Rapid Molecular Detection System for Green Mold Disease of <i>Ganoderma lingzhi</i> Caused by <i>Trichoderma longibrachiatum</i>.

Life (Basel, Switzerland)·2026
Same author

Copper and PFOS Co-Exposure Induces Synergistic Neurotoxicity via ROS-Mediated Mitophagy in <i>C. elegans</i>.

Toxics·2026
Same author

Effects of forest park's biological sounds on the positive responses of stressed university student.

iScience·2026

Related Experiment Video

Updated: Jan 15, 2026

Predicting Treatment Response to Image-Guided Therapies Using Machine Learning: An Example for Trans-Arterial Treatment of Hepatocellular Carcinoma
04:09

Predicting Treatment Response to Image-Guided Therapies Using Machine Learning: An Example for Trans-Arterial Treatment of Hepatocellular Carcinoma

Published on: October 10, 2018

8.6K

Predicting one-year overall survival in patients with AITL using machine learning algorithms: a multicenter study.

Xufei Huang1, Chunlan Zhang2, Kejia Liu3

  • 1Fujian Provincial Key Laboratory on Hematology, Fujian Institute of Hematology, Fujian Medical University Union Hospital, Fujian, China.

Scientific Reports
|October 13, 2025
PubMed
Summary

Machine learning accurately predicts 1-year survival in Angioimmunoblastic T-cell lymphoma (AITL). The Catboost model, using 8 key variables, offers a promising tool for managing this aggressive hematological malignancy.

Keywords:
Angioimmunoblastic t-cell lymphomaMachine learningMulticenter studyOverall survivalPrognosis

More Related Videos

Machine Learning Algorithms for Early Detection of Bone Metastases in an Experimental Rat Model
07:15

Machine Learning Algorithms for Early Detection of Bone Metastases in an Experimental Rat Model

Published on: August 16, 2020

7.4K
Constructing and Visualizing Models using Mime-based Machine-learning Framework
06:19

Constructing and Visualizing Models using Mime-based Machine-learning Framework

Published on: July 22, 2025

2.3K

Related Experiment Videos

Last Updated: Jan 15, 2026

Predicting Treatment Response to Image-Guided Therapies Using Machine Learning: An Example for Trans-Arterial Treatment of Hepatocellular Carcinoma
04:09

Predicting Treatment Response to Image-Guided Therapies Using Machine Learning: An Example for Trans-Arterial Treatment of Hepatocellular Carcinoma

Published on: October 10, 2018

8.6K
Machine Learning Algorithms for Early Detection of Bone Metastases in an Experimental Rat Model
07:15

Machine Learning Algorithms for Early Detection of Bone Metastases in an Experimental Rat Model

Published on: August 16, 2020

7.4K
Constructing and Visualizing Models using Mime-based Machine-learning Framework
06:19

Constructing and Visualizing Models using Mime-based Machine-learning Framework

Published on: July 22, 2025

2.3K

Area of Science:

  • Hematology
  • Oncology
  • Computational Biology

Background:

  • Angioimmunoblastic T-cell lymphoma (AITL) is a severe hematological malignancy.
  • Patients with poor prognosis have limited treatment benefits from traditional therapies.
  • Accurate survival prediction is crucial for guiding treatment decisions in AITL.

Purpose of the Study:

  • To develop an interpretable machine learning (ML) model for predicting 1-year overall survival (OS) in AITL patients.
  • To identify key baseline characteristics influencing AITL patient survival.
  • To enhance prognostic accuracy for AITL management.

Main Methods:

  • Utilized data from 223 AITL patients across 4 Chinese centers.
  • Developed and compared five ML algorithms for 1-year OS prediction.
  • Employed Recursive Feature Elimination (RFE) for feature selection and SHAP/LIME for model interpretability.

Main Results:

  • The Catboost model achieved the highest predictive performance with an AUC of 0.8277.
  • After RFE screening, a model with 8 key variables demonstrated strong predictive power (AUC = 0.8125).
  • Interpretable ML methods confirmed the relevance of selected prognostic factors.

Conclusions:

  • An interpretable Catboost model incorporating 8 variables effectively predicts 1-year OS in AITL patients.
  • This ML-based approach can aid clinicians in risk stratification and treatment planning.
  • The study highlights the potential of AI in improving outcomes for hematological malignancies.